NSEUpdates5d ago · 1 Sept 2026, 04:29 pm

Updates

Symbiotec Pharmalab Limited · SYMBIOTEC

✦ AI SummaryRegulatory

Symbiotec Pharmalab Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulation 2015.' and enclosed the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Symbiotec Pharmalab Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulation 2015.'.

Attachments (1)

📄

SYMBIOTEC_01092026162906_Reg_8_2__Code_of_practice_UPSI.pdf

pdf

Download →
View document text
Date: September 01, 2026 Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, C-1, Block G Mumbai - 400001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051. Scrip Code: 544889 Scrip Symbol : SYMBIOTEC ISIN: INE899I01028 ISIN: INE899I01028 Subject: Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (‘SEBI PIT Regulations’), please find enclosed herewith the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information framed under Regulation 8(1) of SEBI PIT Regulations. This is for your information and record. Thanking You, For SYMBIOTEC PHARMALAB LIMITED Salil Jain Company Secretary and Compliance Officer Membership No. A41610 Encl.: as Above Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293